NASDAQ:IOSP - Innospec Stock Price, News & Analysis

$85.00
+0.53 (+0.63 %)
(As of 08/18/2019 09:22 AM ET)
Today's Range
$84.17
Now: $85.00
$86.26
50-Day Range
$84.35
MA: $91.25
$95.18
52-Week Range
$53.07
Now: $85.00
$96.23
Volume129,000 shs
Average Volume107,756 shs
Market Capitalization$2.08 billion
P/E Ratio17.60
Dividend Yield1.18%
Beta1.29
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash Flow$6.9444 per share
Book Value$35.25 per share

Profitability

Net Income$85 million

Miscellaneous

Employees2,000
Market Cap$2.08 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.


Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, May 7th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.50 per share on Thursday, May 30th. This represents a yield of 1.18%. The ex-dividend date is Monday, May 20th. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its earnings results on Tuesday, August, 6th. The specialty chemicals company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.10 by $0.02. The specialty chemicals company earned $362.40 million during the quarter, compared to analysts' expectations of $371.20 million. Innospec had a return on equity of 15.11% and a net margin of 6.10%. The firm's quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.80 EPS. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Innospec.

What price target have analysts set for IOSP?

1 Wall Street analysts have issued 12 month target prices for Innospec's stock. Their predictions range from $83.00 to $83.00. On average, they anticipate Innospec's stock price to reach $83.00 in the next twelve months. This suggests that the stock has a possible downside of 2.4%. View Analyst Price Targets for Innospec.

What is the consensus analysts' recommendation for Innospec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.

Has Innospec been receiving favorable news coverage?

News articles about IOSP stock have been trending negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Innospec earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Innospec.

Are investors shorting Innospec?

Innospec saw a increase in short interest in July. As of July 15th, there was short interest totalling 382,000 shares, an increase of 6.1% from the June 15th total of 359,900 shares. Based on an average daily trading volume, of 107,200 shares, the days-to-cover ratio is presently 3.6 days. Approximately 1.6% of the company's shares are sold short. View Innospec's Current Options Chain.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Who are Innospec's key executives?

Innospec's management team includes the folowing people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.93%), Vanguard Group Inc. (10.52%), Wells Fargo & Company MN (4.99%), Price T Rowe Associates Inc. MD (2.49%), Northern Trust Corp (2.27%) and Janus Henderson Group PLC (1.72%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which major investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Westwood Holdings Group Inc., First Wilshire Securities Management Inc., Eagle Asset Management Inc., SG Americas Securities LLC, James Investment Research Inc., Emerald Advisers LLC, Kirr Marbach & Co. LLC IN and Acadian Asset Management LLC. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which major investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Janus Henderson Group PLC, Janus Henderson Group PLC, Wasatch Advisors Inc., Jacobs Levy Equity Management Inc., Northern Trust Corp, Wells Fargo & Company MN and Zacks Investment Management. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $85.00.

How big of a company is Innospec?

Innospec has a market capitalization of $2.08 billion and generates $1.48 billion in revenue each year. The specialty chemicals company earns $85 million in net income (profit) each year or $4.83 on an earnings per share basis. Innospec employs 2,000 workers across the globe.View Additional Information About Innospec.

What is Innospec's official website?

The official website for Innospec is http://www.innospecinc.com/.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  220 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  437
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel